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Background and aims: Quality of life (QOL) is poor in hemodialysis (HD) patients. High oxidative stress 
and inflammatory conditions disturb their normal physiological, emotional, and physical functions. 
This study aimed to assess the effects of pomegranate peel extract (PPE) alone and in combination with 
vitamin E (Vit E) as anti-oxidant and anti-inflammatory substances on QOL of HD patients using Short-
form 36 (SF-36) QOL questionnaire. 
Methods: This study was a double-blinded, placebo-controlled randomized clinical trial on HD 
patients. A total of 100 HD patients were randomly divided into 4 equal groups as follows: Pom+Vit E 
group, which received 2 PPE tablets + 1 Vit E soft gel daily, Pom group, which received 2 PPE tablets+1 
Vit E placebo soft gel daily, Vit E group, which received 1 Vit E soft gel+2 PPE placebo tablets daily, and 
Placebo group, which received 2 PPE placebo tablets + 1 Vit E placebo soft gel daily. The intervention 
duration was 8 weeks. The stratified block randomization method based on sex, age, HD duration, and 
employment status was used for randomization. 
Results: The mean age of participants ranged between 51 and 57 years with an HD duration of 9-11.2 
months. Bodily pain score and general health score significantly increased in the Pom group and Pom+ 
Vit E group. The emotional role functioning score of the Pom+Vit E group was significantly higher than 
that of the placebo group (P < 0.05). 
Conclusion: The consumption of PPE and Vit E had beneficial effects on mental components but not the 
physical components of QOL. Moreover, combination therapy was more effective than single therapy. 
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Hemodialysis (HD) improves the survival of patients with 
end-stage renal failure. Many of these patients, who were 
previously threatened with death, experience a relatively 
normal life with HD procedure later and are more or less 
able to perform their personal tasks. However, health-
related outcomes can still be poor in HD patients. Their 
morbidity and mortality rate are higher compared to the 
general population.1 Studies have shown that the quality 
of life (QOL) is poor in HD patient population.1,2 In 
addition to the chronic nature of underlying kidney 
disorder which influences physical, emotional, and social 
abilities of HD patients, higher incidence of cardiovascular 
events also affects their general health status.2 It has been 
reported that HD patients are in high levels of oxidative 
stress and chronic inflammatory status.3 Clinical trials 
have shown that the consumption of anti-inflammatory 
agents or antioxidants in patients with chronic disorders 
not only ameliorates the inflammation but also improves 
the health status and QOL of these patients.4,5
Fruits are good sources of polyphenols, tannins, and 
carotenoids which are known as powerful antioxidants. 
Pomegranate (Punica granatum L.), a valuable source of 
polyphenols and anthocyanins, is shown to have beneficial 
effects on human health and reduce the risk of chronic 
diseases like diabetes, atherosclerosis, and malignancies.6 
Recently, researchers tend to use natural antioxidants 
in HD patients in order to improve their health status. 
Pomegranate peel is the thin interior layer of the fruit that 
covers the pomegranate seeds. It is the richest source of 
flavonoids and tannins in this fruit which is characterized 
as a powerful natural antioxidant and anti-inflammatory 
substance.7 Vitamin E (Vit E) is also a well-known 
antioxidant and anti-inflammatory drug.8 The beneficial 
effects of single therapy with pomegranate or Vit E for 
HD patients have been studied before.9,10 We hypothesized 
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that the consumption of pomegranate and vitamin E may 
have beneficial effects on the health status of HD subjects. 
This study aimed to assess the effects of pomegranate peel 




This study was a double-blinded, placebo-controlled 
randomized clinical trial which assessed the effects of PPE 
and Vit E on the health status of HD patients referred 
to HD centers in Chaharmahal-va-Bakhtiari province, 
Iran. Regarding one of the oxidative stress markers 
(malondialdehyde) as a key variable in this project, 17 
subjects were needed in each group. We enrolled 25 
subjects in each group. The inclusion criteria were as 
follows: HD duration ≥3 months and 3 times a week, 
not having any disorders or using medicines that interfere 
with our intervention like liver diseases, and not using 
antioxidant and anti-inflammatory drugs. During the 
intervention, we excluded the participants who could not 
tolerate the medicines or change their dietary patterns.
Randomization, Blinding, and Study Design
Group allocation was performed by stratified block 
randomization based on sex, age, HD duration, and 
employment status using Random Allocation software. 
The random sequence was generated by someone who 
was not involved in the intervention. Subjects were 
divided into 4 equal groups as follows: Pom + Vit E group, 
which received 2 PPE tablets + 1 Vit E soft gel daily, Pom 
group, which received 2 PPE tablets + 1 Vit E placebo 
soft gel daily, Vit E group, which received 1 Vit E soft 
gel + 2 PPE placebo tablets daily, and placebo group, 
which received 2 PPE placebo tablets + 1 Vit E placebo 
soft gel daily. Participants and investigators were blinded 
to the randomization, group allocation, and content of the 
intervention. The allocation was concealed until the end 
of the study. The intervention duration was 8 weeks. 
Drug Preparation
Pomegranate tablets (225 mg PPE) were obtained from 
Amin Pharmaceutical Company, Iran, and Vit E 400 IU 
soft gels (dL-Alpha-Tocopheryl Acetate) were purchased 
from Zahravi Pharmaceutical Company, Iran. The 
placebos were also prepared by the same companies and 
were identical with the main drugs in size, shape, color, 
and packaging. The drugs were coded with sequential 
numbers by someone not involved in the intervention. 
The patients used the tablets after dialysis.
QOL Assessment
The QOL was assessed by widely used Short-form 36 (SF-
36) QOL Questionnaire. The SF-36 questionnaire is a 
standard method designed by Ware et al. for evaluation 
of the QOL in patients and healthy subjects.11 It has 
36 questions, which assess the QOL in 8 domains of 
vitality, physical functioning, bodily pain, general health 
perceptions, physical role functioning, emotional role 
functioning, social role functioning, and mental health. 
For each question, there are a minimum of 2 and a 
maximum of 6 options to answer. The options are graded 
from 0 to 100, which show the lowest and the highest 
levels of performance, respectively. The final score of each 
option is the sum of the scores for each of the questions 
in that option divided by the number of the questions. 
Therefore, the final score of each domain ranges from 0 
(the lowest score) to 100 (the highest score). The scores 
range from 0–49, 50–74, and ≥75, which are considered as 
poor, relatively favorable, and favorable, respectively. This 
questionnaire can also be summarized in 2 components: the 
physical component scale (including physical functioning 
and physical role functioning domains) and the mental 
component scale (including the other domains). The 
acceptable reliability of the questionnaire for HD patients 
was previously assessed.12,13 The validated Persian version 
of SF-36 QOL questionnaire was used in this study.14 The 
QOL questionnaires were completed by 2 persons who 
were not aware of group allocation and the content of the 
intervention. Demographic data and the duration of HD 
were collected from the participants. 
Statistical Analysis
Quantitative data were represented as mean  ±  SD 
while qualitative data were expressed as numbers and 
percentages. Normality of variables was examined by 
Kolmogorov-Smirnov test and Q-Q plot (Table 1). 
Within-group changes from baseline were assessed by 
analysis of paired samples t test. Pearson’s chi-square test 
was used to compare categorical variables. Multivariate 
analysis of covariance (MANCOVA) was used to show 
between-group differences after adjusting the baseline 
variables, age, and dialysis duration. Analyses were 
performed by SPSS version 20.0. A P value ≤0.050 was 
considered statistically significant.
Results
At first, 120 HD patients were evaluated. According to 
the inclusion criteria, 100 HD patients were selected for 
the study and randomly divided into 4 equal groups. 
Demographic data and baseline characteristic variables 
of participants are shown in Table 2. There were no 
statistically significant differences in age, sex, body mass 
index (BMI), and other baseline variables between the 
groups. During the 8-week intervention, 3 subjects 
were excluded from the study (one person died in the 
second week, one withdrew, and one person changed the 
treatment) and 97 participants completed the study. The 
CONSORT flow diagram of the study is shown in Figure 
1. Except for the score of emotional role functioning that 
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was relatively favorable (>50), the rest of pre-intervention 
QOL scores of HD patients were poor (<50 in most of 
the domains), which represented that the participants were 
not in a good condition. The baseline scores of QOL are 
shown in Table 3.
Effect of Interventions on Vitality
After 8-week interventions, the vitality score significantly 
increased in Pom + Vit E group while it did not significantly 
change in the other groups. Results of the MANCOVA test 
revealed that there were no significant differences between 
the groups in the vitality domain after the interventions 
(Table 3).  
Effect of Interventions on Physical Functioning
Results of the paired samples t-test showed that physical 
functioning scores did not significantly change in the 
groups after the intervention. Results of the MANCOVA 
test showed that 8-week interventions could not 
significantly increase the physical functioning score of the 
patients (Table 3).
 
Effect of Interventions on Bodily Pain
Bodily pain score significantly increased in the Pom group 
and Pom + Vit E group, while it decreased in the placebo 
group compared to the baseline. Comparison of between-
group differences (MANCOVA test) revealed that our 
interventions significantly altered the bodily pain scores 
(Table 3). Post hoc analyses demonstrated that a significant 
difference was found between Pom + Vit E and placebo 
groups (MANCOVA test, post hoc analyses, P < 0.01).
 
Effect of Interventions on General Health Perception
Results of paired t test revealed that after 8-week 
interventions, the score of general health perception 
significantly decreased in the placebo group while it 
increased in the other groups and its increase was more 
considerable in the Pom + Vit E group. There was also 
Table 1. Results of Kolmogorov-Smirnov Test
QOL Domain
Intervention Groups
Placeboa Pomb Vit Ec Pom + Vit Ed
Z P-valuee Z P-valuee Z P-valuee Z P-valuee
Vitality 0.793 0.907 0.543 0.153 0.111 0.788 0.444 0.899
Physical functioning 0.554 0.123 0.556 0.276 0.836 0.855 0.856 0.133
Bodily pain 0.765 0.453 0.135 0.356 0.323 0.464 0.999 0.777
General health perceptions 0.738 0.456 0.764 0.666 0.333 0.855 0.453 0.677
Physical role functioning 0.346 0.738 0.455 0.203 0.888 0.693 0.323 0.870
Emotional role functioning 0.523 0.273 0.957 0.744 0.489 0.243 0.522 0.168
Social role functioning 0.759 0.254 0.777 0.229 0.854 0.677 0.434 0.155
Mental health 0.240 0.530 0.486 0.932 0.456 0.753 0.512 0.240
Data shows the results of Z and P value of each variable in K-S test. 
a Received 3 placebo pills.
b Received 2 pomegranate peel extract (PPE) tablets +1 vitamin E (Vit E) placebo.
c Received 1 Vit E + 2 PPE placebo.
d Received 2 PPE tablets + 1 Vit E.
e Obtained from K-S test, showing normal distribution of variables.




Placeboa Pomb Vit Ec Pom + Vit Ed
Age (year) 56.45 ± 16.14 57.50 ± 17.02 52.04 ± 16.94 51.16 ± 12.92 0.285
Gender (female/male) 12/12 14/11 13/11 10/14 0.933
BMI (kg/m2) 23.08 ± 3.90 23.58 ± 3.16 23.40 ± 3.17 24.63 ± 3.38 0.430
HD duration (month) 11.00 ± 6.74 9.33 ± 5.34 11.21 ± 7.44 10.83 ± 6.00 0.765
Marital status (married/single) 23/1 25/0 24/0 23/1 0.816
Urban/rural 6/18 6/19 5/19 6/18 0.509
Employment status (employed/unemployed) 9/15 12/13 11/13 12/12 0.322
Insurance status (yes/no) 24/0 24/1 23/1 24 0.750
Data are expressed as mean  ±  SD.
a Received 3 placebo pills.
b Received 2 pomegranate peel extract (PPE) tablets +1 vitamin E (Vit E) placebo.
c Received 1 Vit E + 2 PPE placebo.
d Received 2 PPE tablets + 1 Vit E.
e Obtained from ANOVA.
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Assessed for eligibility (n=120)
Excluded (n=20)
¨ Not meeting inclusion criteria (n=17)
¨ Declined to participate (n=3)
Analysed (n=24)
• Received allocated 
intervention (n= 24)
• Did not receive allocated 
intervention (n=1,withdrew)
Allocated to Placebo group 
(n=25)
(3 placebo pills)
• Received allocated 
intervention (n= 24)
• Did not receive allocated 
intervention (n=1,changed the 
treatment)
Allocated to Pom+Vit E group 
(n=25)








Allocated to Pom group 
(n=25)
(2 pomegranate Tablets +1 
vitamin E placebo)
Allocated to Vit E group (n=25)
(1 vitamin E + 2 pomegranate 
placebo)
• Received allocated 
intervention (n= 25)
• Received allocated intervention 
(n= 24)
• Did not receive allocated 
intervention (n=1,died)
Analysed (n=25) Analysed (n=24)
Figure 1. CONSORT Flow Diagram of Study Design
a significant between-group difference according to 
MANCOVA tests (Table 3), and based on post hoc analyses, 
all the scores were significantly higher in intervention 
groups compared to the placebo group (MANCOVA test, 
post hoc analyses, P < 0.05).
Effect of Interventions on Physical Role Functioning
Eight-week interventions did not significantly change 
the scores of physical role functioning. Results of the 
MANCOVA test also revealed that there was no significant 
between-group difference in this domain after the 
interventions (Table 3).
 
Effect of Interventions on Emotional role Functioning
Table 3 shows that the interventions did not significantly 
change the scores of emotional role functioning after 8 
weeks, while the MANCOVA test indicated a significant 
difference in post-intervention scores among the groups 
(Table 3). Results of post hoc analyses showed that this 
score was significantly higher in Pom + Vit E group than 
in the placebo group (MANCOVA test, post hoc analyses, 
P < 0.050). 
Effect of Interventions on Social Role Functioning
Our interventions did not significantly change the 
scores of social role functioning. The MANCOVA test 
also indicated that there were no significant differences 
between the groups in post-intervention scores of this 
domain (Table 3). 
Effect of Interventions on Mental Health
As shown in Table 3, the score of mental health significantly 
increased in the Pom group while it did not significantly 
change in the other groups. Results of the MANCOVA 
test showed that our intervention significantly altered 
the post-intervention scores (Table 3). Post hoc analyses 
revealed that the mental health score was significantly 
higher in Pom + Vit E group compared to the placebo 
group (MANCOVA test, post hoc analyses, P < 0.050). 
The Overall Effects of Interventions on the Physical 
Component Scale and Mental Component Scale
Our 8-week interventions did not significantly change 
the physical component scale, while they significantly 
changed the scores of the mental component scale (Table 
4). Results of the post hoc analyses represented that mental 
component scale significantly increased in the Pom + 
Vit E, Pom, and Vit E groups compared to the placebo 
group after the interventions (Figure 2), while there were 
no significant differences in the physical component scale 
among the groups (Figure 3). 
Discussion
Our study indicated that the consumption of PPE alone or 
in combination with Vit E did not improve the physical-
related domains, while it significantly ameliorated the 
mental-related domains of QOL in HD subjects. Few 
studies have evaluated the QOL scores in HD patients and 
reported poor QOL in these patients.12-16 Ibrahim and El 
Salamony evaluated 60 HD patients in Egypt and reported 
that their QOL scores were poor (<50 score in all domains). 
They also found that the high prevalence of depression in 
these patients was associated with poor QOL.16 Gencer et 
al studied 109 HD subjects in Turkey. They reported poor 
QOL status in these patients, which was related to high 
malnutrition status. 17
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Oxidative stress is characterized by an imbalance between 
the body antioxidant defense and the accumulation of 
oxidative products such as reactive oxygen and nitrogen 
species.18 In this situation, oxidative molecules trigger 
the oxidation of the biological substance and molecules 
such as carbohydrates, proteins, nucleic acids, and lipids 
and, therefore, destroy the physiological functions of the 
organism.19 Oxidative stress is almost always associated 
with chronic inflammation. Inflammation is a vital 
physiologic response of organisms against pathogens 
and life-threatening factors. In some conditions, this 
response is prolonged and destructive, and high levels of 
inflammatory markers in addition to oxidative products 
promote disorders such as chronic kidney disease.4,20,21 
The number of patients with chronic renal failure is 
increasing worldwide. HD is a way to compensate for the 
loss of kidney function and increases the patients’ survival. 
HD patients also have high levels of inflammation and 
oxidative stress, which affect their health status. High 
serum levels of free radicals, reactive oxygen species, as well 
as inflammatory markers are associated with a reduction in 
mental health and physical functions.22,23
Due to the valuable antioxidative capacity of 
pomegranate, many studies have used this fruit and its 
extracts in order to improve the health status of patients 
with chronic or metabolic disorders.7,24,25 It seems that 
the improvement of antioxidative defense and reduction 
of the inflammation in HD patients ameliorate their 
health status, thereby improving their QOL score. As it 
was revealed in this study, the consumption of antioxidant 
and anti-inflammatory substances (PPE alone or in 
combination with vitamin E) for 8 weeks ameliorated the 
domain of mental health, especially when the participants 
used both PPE and vitamin E. It can be concluded that the 
combination of PPE and Vit E strengthens the antioxidative 
and anti-inflammatory properties of each other. To our 
knowledge, this is the first study that evaluated the effects 
of antioxidants and anti-inflammatory drugs on QOL in 
HD patients. Considering the health conditions of our 
participants, we were not able to have a longer intervention 
period and this can be a limitation of this study.
Conclusion
The current study revealed that the consumption of 
PPE and Vit E had beneficial effects on the mental 
components of QOL in HD patients. We also concluded 
that combination therapy has more benefits compared to 
single therapy. We suggest further studies in this field with 
longer period of intervention as well as evaluation of other 
antioxidant and anti-inflammatory drugs.
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Figure 2. The Overall Effects of Pomegranate Peel Extract (PPE) and Vitamin E (Vit E) on Mental Component Scale. Means ± SD with 





















Figure 2. The Overall Effects of Pomegranate Peel Extract (PPE) and 
Vitamin E (Vit E) on Mental Component Scale. Means  ±  SD with 




Figure 3. The Overall Effects of Pomegranate Peel Extract (PPE) and Vitamin E (Vit E) on Physical Component Scale. Means ± SD with the 

































Figure 3. The Overall Effects of Pomegranate Peel Extract (PPE) and 
Vitamin E (Vit E) on Physical Component Scale. Means  ±  SD with 
the same letter are not significantly different (P > 0.05).
Table 4. Overall Effects of Interventions on Quality of Life (QOL) Scales
QOL scale
Intervention Groups Between Groups 
P-valueePlaceboa Pomb Vit Ec Pom + Vit Ed
Physical component 45.0 ± 13.0 44.3 ± 9.6 46.1 ± 12.5 43.0 ± 8.1 0.246
Emotional component 41.2 ± 9.7 48.4 ± 8.1 50.1 ± 10.2 53.0 ± 10.4 <0.001
Data are expressed as mean  ±  SD.
a Received 3 placebo pills.
b Received 2 pomegranate peel extract (PPE) tablets +1 vitamin E (Vit E) placebo.
c Received 1 Vit E + 2 PPE placebo.
d Received 2 PPE tablets + 1 Vit E.
e Obtained from MANOVA.
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out by all participants.
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